Novel lysine‐specific histone demethylase 1 inhibitor in acute myeloid leukaemia transformed from essential thrombocythaemia

BACKGROUND: While progress continues in the understanding of molecular abnormalities in acute myeloid leukaemia (AML), with some specific targeted therapies now available, it remains commonly fatal in the elderly. Leukaemic evolution and transformation from myeloproliferative neoplasms (MPN) may be...

Descripción completa

Detalles Bibliográficos
Autores principales: Hodges, Samantha, Cooney, Julian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9351673/
https://www.ncbi.nlm.nih.gov/pubmed/34786883
http://dx.doi.org/10.1002/cnr2.1588

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9351673/
https://www.ncbi.nlm.nih.gov/pubmed/34786883
http://dx.doi.org/10.1002/cnr2.1588

Ejemplares similares